Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
64 Cards in this Set
- Front
- Back
|
Norco indication |
Moderate to moderately severe pain |
|
|
Norco Dosaging |
1-2 tabs q 4-6 h (prn) |
|
|
Vicoprofen indication |
Acute pain |
|
|
Vicoprofen Dosaging |
1 tab q 4 to 6 h (prn) |
|
|
MS Contin indication |
moderate to severe pain |
|
|
MS Contin Dosaging |
Individualized q 8-12 h |
|
|
MS IR indication |
moderate to severe pain |
|
|
MS IR dosaging |
Prn breakthrough pain |
|
|
Oxycontin indication |
moderate to severe pain |
|
|
Oxycontin dosaging |
individualized q 12 h |
|
|
Percocet indication |
moderate to moderately severe pain |
|
|
Percocet dosaging |
1 tab q 6 h (prn) |
|
|
Tylenol w/ Codeine # 2 or 3 indication |
mild to moderate pain |
|
|
Tylenol w/ Codeine # 2 or 3 dosaging |
1-2 tabs q 4 h (prn) |
|
|
Ultram indication |
moderate to moderately severe pain |
|
|
Ultram dosaging |
50-100mg q 4-6 h (prn) |
|
|
Ultracet indication |
acute pain |
|
|
Ultracet dosaging |
2 tabs q 4-6 h (prn) |
|
|
Dolophine indication |
detoxification or maintenance treatment of opioid addiction, and moderate to severe pain |
|
|
Dolophine dosaging |
individualized |
|
|
Duragesic indication |
chronic pain |
|
|
Duragesic dosaging |
individualized (apply patch q 72 h) |
|
|
Demerol indication |
moderate to moderately sever pain |
|
|
Demerol dosaging |
50-150mg q 3-4 h (prn) |
|
|
Stadol indication |
pain |
|
|
Stadol dosaging |
injectable, nasal spray |
|
|
Talwin NX indication |
moderate to severe pain |
|
|
Nalwin NX dosaging |
oral tab |
|
|
Suboxone indication |
opioid dependence |
|
|
Suboxone dosaging |
4-24 mg/day (based on buprenorphine) |
|
|
Neurontin indication |
adjunct in seizure disorders, neuropathic pain |
|
|
Neurontin dosaging |
300-600mg tid |
|
|
Tegretol/XR indication |
seizure disorders |
|
|
Tegretol/XR dosaging |
800-1200 mg per day in divided doses |
|
|
Nicoderm, Nicotrol, Nicorette indication |
treatment to aid in smoking cessation; decrease nicotine withdrawal symptoms. |
|
|
Nicoderm dosaging |
21,14,7 mg/day based on smoking habit, taper dose |
|
|
Nicorette dosaging |
chew up to 24 gum pieces/day of 2 or 4 mg |
|
|
Nicotrol dosaging |
6-16 cartridges/day |
|
|
Chantix indication |
aid in smoking cessation |
|
|
Chantix dosaging |
day 1-3: 0.5mg daily, day 4-7: 0.5mg bid, then >days6-8: 1mg bid |
|
|
Zyban indication |
major depression or smoking cessation |
|
|
Zyban dosaging |
150mg daily for 3 days, then 150 mg bid |
|
|
Zofran indication |
Chemotherapy induced NV |
|
|
Zofran dosaging |
8mg bid (30 min pre- and in 8 hours) |
|
|
Phenergan indication |
antiemetic/antivertigo |
|
|
Phenergan dosaging |
25mg q 4-6h for antiemetic 25mg bid for antivertigo |
|
|
Compazine indication |
severe NV |
|
|
Compazine dosaging |
5-10 mg tid-qid |
|
|
Compazine Spansule dosaging |
10mg q 12 h or 15mg qam |
|
|
Reglan indicationS |
diabetic gastoparesis and symptomatic GERD |
|
|
Reglan dosaging |
5-10mg qid (30 min ac and qhs prn) for diabetic gastoparesis 5-15mg up to qid (30 min ac and qhs) for symptomatic GERD |
|
|
Antivert indication |
vertigo |
|
|
Antivert dosaging |
25-100mg/day in divided doses |
|
|
Lomotil indication |
diarrhea |
|
|
Lomotil dosaging |
2 tabs or tsp qid initially, then 1 tab qd-bid |
|
|
Imodium AD indication |
diarrhea |
|
|
Imodium AD dosaging |
2 tabs after 1st loose BM; then 1 after subsequent loose BM |
|
|
D5W, NS, 1/2 NS, D5 1/2 NS, D5 1/4 NS indication |
fluid management and injection vehicle |
|
|
D5W and NS dosaging |
50,100,250,500,1000 ml |
|
|
1/2 NS, D5 1/2 NS, D5 1/4 NS dosaging |
500 and 1000 ml |
|
|
NaHCO3 indication |
acid base management |
|
|
NaHCO3 dosaging |
inj 4.2%, 7.5%, 8.4% |
|
|
NaAcetate indication |
acid base management |
|
|
NaAcetate dosaging |
2 or 4 mEq/ml |
